Skip to content
10-K

Annual Report

ACCELERON PHARMA INC.

0001280600-21-000017

← back to feed
Filed
Feb 25, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Jan 31, 2021 60.55M sh
Capex FY 2020 · Dec 31, 2020 $4.2M
Capex FY 2020 · Dec 31, 2019 $3.29M
Capex FY 2020 · Dec 31, 2018 $2.59M
Operating Cash Flow FY 2020 · Dec 31, 2020 −$130.33M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$93.8M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$94.71M
Short Term Investments FY 2020 · Dec 31, 2020 $178.95M
Short Term Investments FY 2020 · Dec 31, 2019 $193.69M
Cash And Equivalents FY 2020 · Dec 31, 2020 $670.95M
Cash And Equivalents FY 2020 · Dec 31, 2019 $237.68M
Cash And Equivalents FY 2020 · Dec 31, 2018 $144.05M
Stockholders Equity FY 2020 · Dec 31, 2020 $855.11M
Stockholders Equity FY 2020 · Dec 31, 2019 $449.48M
Stockholders Equity FY 2020 · Dec 31, 2018 $292.04M
Stockholders Equity FY 2020 · Dec 31, 2017 $365.22M
Current Liabilities FY 2020 · Dec 31, 2020 $60.16M
Current Liabilities FY 2020 · Dec 31, 2019 $33.37M
Total Liabilities FY 2020 · Dec 31, 2020 $77.23M
Total Liabilities FY 2020 · Dec 31, 2019 $55.43M
Current Assets FY 2020 · Dec 31, 2020 $893.27M
Current Assets FY 2020 · Dec 31, 2019 $449.92M
Total Assets FY 2020 · Dec 31, 2020 $932.34M
Total Assets FY 2020 · Dec 31, 2019 $504.91M
Sga Expense FY 2020 · Dec 31, 2020 $85.91M
Sga Expense FY 2020 · Dec 31, 2019 $56.49M
Sga Expense FY 2020 · Dec 31, 2018 $34.5M
Rd Expense FY 2020 · Dec 31, 2020 $173.92M
Rd Expense FY 2020 · Dec 31, 2019 $153.95M
Rd Expense FY 2020 · Dec 31, 2018 $103.9M
Net Income FY 2020 · Dec 31, 2020 −$57.4M
Net Income FY 2020 · Dec 31, 2020 −$166.03M
Net Income FY 2020 · Sep 30, 2020 −$39.25M
Net Income FY 2020 · Jun 30, 2020 −$18.45M
Net Income FY 2020 · Mar 31, 2020 −$50.94M
Net Income FY 2020 · Dec 31, 2019 −$23.58M
Net Income FY 2020 · Dec 31, 2019 −$124.86M
Net Income FY 2020 · Sep 30, 2019 −$45.37M
Net Income FY 2020 · Jun 30, 2019 −$17.86M
Net Income FY 2020 · Mar 31, 2019 −$38.05M
Net Income FY 2020 · Dec 31, 2018 −$118.87M
Operating Income FY 2020 · Dec 31, 2020 −$57.6M
Operating Income FY 2020 · Dec 31, 2020 −$167.31M
Operating Income FY 2020 · Sep 30, 2020 −$39.23M
Operating Income FY 2020 · Jun 30, 2020 −$18.91M
Operating Income FY 2020 · Mar 31, 2020 −$51.57M
Operating Income FY 2020 · Dec 31, 2019 −$25.58M
Operating Income FY 2020 · Dec 31, 2019 −$136.45M
Operating Income FY 2020 · Sep 30, 2019 −$48.92M
Operating Income FY 2020 · Jun 30, 2019 −$21.14M
Operating Income FY 2020 · Mar 31, 2019 −$40.81M
Operating Income FY 2020 · Dec 31, 2018 −$124.41M
Revenue FY 2020 · Dec 31, 2020 $25.87M
Revenue FY 2020 · Dec 31, 2020 $92.52M
Revenue FY 2020 · Sep 30, 2020 $22.56M
Revenue FY 2020 · Jun 30, 2020 $39.75M
Revenue FY 2020 · Mar 31, 2020 $4.34M
Revenue FY 2020 · Dec 31, 2019 $39.34M
Revenue FY 2020 · Dec 31, 2019 $73.99M
Revenue FY 2020 · Sep 30, 2019 $4.21M
Revenue FY 2020 · Jun 30, 2019 $27.67M
Revenue FY 2020 · Mar 31, 2019 $2.78M
Revenue FY 2020 · Dec 31, 2018 $13.99M